Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature

D. Green, K. J. Friedman

Research output: Contribution to journalArticle

Abstract

Cutaneous pigmentation associated with minocycline ingestion is an unusual adverse effect for which few treatments have been described. Within the past few years, treatment with different Q-switched lasers has been reported in the literature. The purpose of this therapeutic intervention was to determine whether the Q-switched Alexandrite laser could clinically and histologically improve pigmentation associated with minocycline ingestion. A patient with type II minocycline pigmentation was treated with the Q-switched Alexandrite (755 nm) laser and then evaluated clinically and histologically to determine the outcome of this intervention. Treatment with the Q-switched Alexandrite (755 nm) laser provided excellent clinical and histologic clearing of minocycline pigmentation. One year after completion of laser treatment, the skin has remained clinically clear with no recurrence. The Q-switched Alexandrite laser (755 nm) should be considered for treatment of type II minocycline pigmentation.

Original languageEnglish (US)
Pages (from-to)342-347
Number of pages6
JournalJournal of the American Academy of Dermatology
Volume44
Issue number2 SUPPL.
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature'. Together they form a unique fingerprint.

  • Cite this